نتایج جستجو برای: multidrug resistant mycobacterium tuberculosis mdr

تعداد نتایج: 311140  

Journal: :Iranian journal of immunology : IJI 2010
Ali Shams Shahemabadi Ahmad Zavaran Hosseini Shapour Shaghasempour Mohammad Reza Masjedi Majid Rayani Majid Shams Nasrin Esphandyari Majid Pouramiri

BACKGROUND Mycobacterium tuberculosis lipid antigens take part in pathogenicity of the bacterium but the response of monocytes/macrophages to these antigens in tuberculosis is not well known. OBJECTIVE The aim of current investigation was to study the M. tuberculosis lipid antigens in tuberculosis pathogenesis. METHODS In the present study M. tuberculosis lipid antigens were extracted. Mono...

Journal: :Journal of research in health sciences 2015
Jalil Rashedi Behroz Mahdavi Poor Abdolnasser Rafi Mohammad Asgharzadeh Jalal Abdolalizadeh Seyyed Reza Moaddab

BACKGROUND Republic of Azerbaijan is considered as an area with high prevalence of multi-drug resistant tuberculosis. Uncontrolled travelling of Azerbaijanis people to Iran is the issue that needs to be considered as an important issue. METHODS This study was conducted on 32 patients with tuberculosis from Baku-Nakhchivan and 48 patients from Iran during 2012 to 2014. Colonies of Mycobacteriu...

Journal: :Journal of clinical microbiology 2012
Xiaobing Zhang Bing Zhao Liguo Liu Yafang Zhu Yanlin Zhao Qi Jin

The presence of heteroresistance was represented by 23% of 235 fluoroquinolone (FQ)-resistant Mycobacterium tuberculosis isolates in Beijing, China, from 2008 to 2010. The main mechanism of FQ heteroresistance is due to the segregation of a single M. tuberculosis strain in patients; the majority of isolates with multidrug-resistant tuberculosis contained a mixture of bacterial subpopulations co...

Journal: :The European respiratory journal 2013
Noor Alsaad Richard van Altena Arianna D Pranger Dick van Soolingen Wiel C M de Lange Tjip S van der Werf Jos G W Kosterink Jan-Willem C Alffenaar

Co-trimoxazole (SXT), a combination of sulfamethoxazole and trimethoprim, has shown in vitro activity against Mycobacterium tuberculosis. However, the pharmacokinetic and pharmacodynamic parameters of SXT in multidrug-resistant (MDR) tuberculosis (TB) are, thus far, lacking. Therefore, we evaluated its pharmacokinetics and drug susceptibility, along with its tolerability during treatment. Based...

2015
A. Nusrath Unissa N. Selvakumar Sujatha Narayanan C. Suganthi L. E. Hanna

Mutation at codon 315 of katG gene is the major cause for isoniazid (INH) resistance in Mycobacterium tuberculosis (M. tuberculosis). Substitution at codon 315 of katG gene was analyzed in 85 phenotypically resistant isolates collected from various parts of southern India by direct sequencing method. The obtained results were interpreted in the context of minimum inhibitory concentration (MIC) ...

2016
Ivy Rukasha Halima M. Said Shaheed V. Omar Hendrik Koornhof Andries W. Dreyer Alfred Musekiwa Harry Moultrie Anwar A. Hoosen Gilla Kaplan Dorothy Fallows Nazir Ismail

Treatment of tuberculosis (TB) and HIV co-infections is often complicated by drug-to-drug interactions between anti-mycobacterial and anti-retroviral agents. Rifabutin (RFB) is an alternative to rifampin (RIF) for TB regimens and is recommended for HIV patients concurrently receiving protease inhibitors because of reduced induction of CYP3A4. This study sought to determine the proportion of RFB...

2017
Divakar Sharma Yogesh K. Dhuriya Nirmala Deo Deepa Bisht

Emergence of drug resistant tuberculosis like multi drug resistant tuberculosis (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB) and totally drug resistant tuberculosis (TDR-TB) has created a new challenge to fight against these bad bugs of Mycobacterium tuberculosis. Repurposing and revival of the drugs are the new trends/options to combat these worsen situations of tuberculosis in t...

Journal: :The Lancet. Infectious diseases 2013
Patrick K Moonan Larry D Teeter Katya Salcedo Smita Ghosh Shama D Ahuja Jennifer Flood Edward A Graviss

BACKGROUND Multidrug-resistant (MDR) tuberculosis is a potential threat to tuberculosis elimination, but the extent of MDR tuberculosis disease in the USA that is attributable to transmission within the country is unknown. We assessed transmission of MDR tuberculosis and potential contributing factors in the USA. METHODS In a cross-sectional study, clinical, demographic, epidemiological, and ...

Journal: :Journal of clinical microbiology 2007
Nicole Parrish Gerard Osterhout Kim Dionne Amy Sweeney Nicole Kwiatkowski Karen Carroll Kenneth C Jost James Dick

Multidrug-resistant (MDR) Mycobacterium tuberculosis and extrensively drug-resistant (XDR) M. tuberculosis are emerging public health threats whose threats are compounded by the fact that current techniques for testing the susceptibility of M. tuberculosis require several days to weeks to complete. We investigated the use of high-performance liquid chromatography (HPLC)-based quantitation of my...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید